Lonza’s ResistAid™ Provides Immune System Benefits in a Unique Dual Protection Probiotic Supplement, Ultimate Flora Advanced Immunity™

Allendale, NJ, 24 February 2010 – Lonza is pleased to announce the inclusion of its Larch Arabinogalactan (LAG)-based ResistAid™ in Ultimate Flora Advanced Immunity™, from ReNew Life.

The dual-protection probiotic supplement is formulated to support the natural immune defenses in the respiratory system and digestive tract. Ultimate Flora Advanced Immunity™ utilizes the immune-supporting and antioxidant properties of ResistAid™. Simultaneously, the multifunctional product employs ResistAid™ to assist the replenishing of beneficial intestinal bacteria and the support of immune cell production.

“ResistAid™ provides a natural fit for Ultimate Flora Advanced Immunity™, as it offers immune-supporting properties that align with ReNew Life’s standards for a product of the highest quality,” said Bryan Rodriguez, Technical Marketing & Scientific Affairs Manager, Lonza Inc. “As research continues to expand on optimizing the digestive and immune systems, we look forward to providing high quality ingredients backed by science to individuals seeking to support each of these health systems.”

In keeping with ReNew Life’s commitment to developing the best, most effective digestive care supplements, Ultimate Flora Advanced Immunity™ contains no fillers or binders and is made with only premium natural ingredients. An all-natural ingredient, ResistAid™ is produced by a specific extraction process utilizing steam-heating. This unique water-based extraction does not introduce any harsh chemicals to release the phenolic and arabinogalactan compounds from the plant matrix; therefore, the product remains pure and structurally unaltered after extraction.

ResistAid™ recently made news in October 2009, as a randomized, double-blind, placebo-controlled, parallel-group study suggesting broadened immune benefits that include the adaptive immune response, which is a response to specific antigens. The study further showed that ResistAid™ may have an immunomodulatory effect, meaning that it supports the appropriate response to an antigen without indiscriminately enhancing other arms of the immune system that would not be utilized in a response.

For more information, visit www.ResistAid.com and www.Renewlife.com.

About ReNew Life
Named America’s No. 1 Digestive Care and Cleansing Company by SPINS, ReNew Life Formulas develops and manufactures a full spectrum of natural digestive care products and functional foods. Founded in 1997 by Brenda Watson and Stan Watson, the company has built a reputation upon making superior-quality products and providing outstanding customer service and educational support.

Each ReNew Life product is made from only the finest raw ingredients, and the company’s analysis and manufacturing practices set the benchmark for others in the industry. Above all, ReNew Life is dedicated to helping their customers achieve and maintain optimal health, increase their energy and enhance their mental clarity.

About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2009, Lonza had sales of CHF 2.69 billion. Further information can be found at www.lonza.com.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

For further information please contact:
Lonza Inc.
Technical Marketing & Scientific Affairs Manager
Bryan Rodriguez
Tel +1 210 231 0478
Fax +1 201 696 3445
[email protected]

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.